Invesco Dynamic Biotech & Genome ETF (PBE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: INVESTMENT ADVICE

3500 LACEY ROAD DOWNERS GROVE, IL 60515

PowerShares Dynamic Biotech & Genome Portfolio is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Index consists of stocks of 30 United States biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture, and marketing and distribution of various biotechnological products, services and processes. As of Apr 30 2012, the Fund's total assets were $137,127,608 and the Fund's investments portfolio was valued at $137,127,585.

Data based on most recent fiscal year report
Market Cap452.865 Million Shares Outstanding9.5 Million Avg Volume29.311 Thousand
View SEC Filings from PBE instead.
Q2 2019 All Institutions Hedge Funds 1
To trade PBE now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 79 2 (0.21%)
Aggregate 13F shares on 06/30/2019: 1.238 Million 17.2 Thousand
Aggregate 13F shares on 03/31/2019: 1.483 Million 51.438 Thousand
Percent change: -16.53% -66.56%
Funds creating new positions: 11
Funds Adding to an existing position: 8
Funds closing out their position: 7 1
Funds reducing their position: 27
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding PBE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments